Header cover image
  • Investing Ideas
  • /
  • Italian Pharmaceuticals & Biotech High Return On Equity, Low Debt

Italian Pharmaceuticals & Biotech High Return On Equity, Low Debt

Results

1

0 new

Stocks with a return on equity of over 30% and a debt to equity ratio below 1.

1 companies

Philogen

Market Cap: €859.1m

A biotechnology company, develops drugs for oncology and chronic inflammatory diseases in Switzerland and the European Union.

PHIL

€21.30

7D

-3.2%

1Y

-1.8%